Patents Assigned to Ophidion Inc.
  • Patent number: 11376331
    Abstract: Compositions and methods are provided including a transporter peptide derived from the loop2 domain of the neuronally-derived lynx1 protein which can be conjugated to an effector agent to form a transporter-effector complex for transport of the therapeutic effector agent to a target that is found across the blood brain barrier.
    Type: Grant
    Filed: September 14, 2020
    Date of Patent: July 5, 2022
    Assignee: OPHIDION INC.
    Inventor: Andreas Walz
  • Patent number: 10772966
    Abstract: Compositions and methods are provided including a transporter peptide derived from the loop2 domain of the neuronally-derived lynx1 protein which can be conjugated to an effector agent to form a transporter-effector complex for transport of the therapeutic effector agent to a target that is found across the blood brain barrier.
    Type: Grant
    Filed: June 24, 2019
    Date of Patent: September 15, 2020
    Assignee: OPHIDION INC.
    Inventor: Andreas Walz
  • Patent number: 10328156
    Abstract: Compositions and methods are provided including a transporter peptide derived from the loop2 domain of the neuronally-derived lynx1 protein which can be conjugated to an effector agent to form a transporter-effector complex for transport of the therapeutic effector agent to a target that is found across the blood brain barrier.
    Type: Grant
    Filed: January 26, 2018
    Date of Patent: June 25, 2019
    Assignee: OPHIDION INC.
    Inventor: Andreas Walz
  • Patent number: 9913915
    Abstract: Compositions and methods are provided including a transporter peptide derived from the loop2 domain of the neuronally-derived lynx1 protein which can be conjugated to an effector agent to form a transporter-effector complex for transport of the therapeutic effector agent to a target that is found across the blood brain barrier.
    Type: Grant
    Filed: November 14, 2016
    Date of Patent: March 13, 2018
    Assignee: Ophidion Inc.
    Inventor: Andreas Walz
  • Patent number: 9522193
    Abstract: Compositions and methods are provided including a transporter peptide derived from the loop2 domain of the neuronally-derived lynx1 protein which can be conjugated to an effector agent to form a transporter-effector complex for transport of the therapeutic effector agent to a target that is found across the blood brain barrier.
    Type: Grant
    Filed: December 9, 2013
    Date of Patent: December 20, 2016
    Assignee: OPHIDION INC.
    Inventor: Andreas Walz
  • Publication number: 20140162961
    Abstract: Compositions and methods are provided including a transporter peptide derived from the loop2 domain of the neuronally-derived lynx1 protein which can be conjugated to an effector agent to form a transporter-effector complex for transport of the therapeutic effector agent to a target that is found across the blood brain barrier.
    Type: Application
    Filed: December 9, 2013
    Publication date: June 12, 2014
    Applicant: OPHIDION INC.
    Inventor: Andreas Walz
  • Patent number: 8629114
    Abstract: Compositions and methods are provided including a transporter peptide derived from the loop2 domain of the neuronally-derived lynx1 protein which can be conjugated to an effector agent to form a transporter-effector complex for transport of the therapeutic effector agent to a target that is found across the blood brain barrier.
    Type: Grant
    Filed: June 3, 2012
    Date of Patent: January 14, 2014
    Assignee: Ophidion Inc.
    Inventor: Andreas Walz